Treatment of gabapentin-induced myoclonus with continuous renal replacement therapy
A K Guddati1, Z Zafar, J T Cheng
1Department of Internal Medicine, Harlem Hospital Center, New York, USA.
Abstract:
A 56-year-old man with diabetes, hypertension, and chronic kidney disease presented to the emergency room with a complaint of pain in his right foot. He was found to have tremors. Gabapentin toxicity was suspected and the patient was found to have high gabapentin level (6.3 mcg/ml). Patient was commenced on continuous venovenous hemodiafiltration (CVVHD) and the pharmacokinetics of gabapentin was studied. The patient improved symptomatically and his tremors subsided. In this case report, we describe the successful management of gabapentin toxicity with continuous renal replacement therapy and calculate the clearance of gabapentin which will enable future treatment of gabapentin toxicity by CVVHD.
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care

